Skip to content

An Integrated Care Model for Chronic Patients

Effectiveness of the Integrated Care Model Salut+Social in Patients With Chronic Conditions: a Mixed Methods Study Protocol

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04164160
Enrollment
141
Registered
2019-11-15
Start date
2019-06-01
Completion date
2020-06-30
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Integrated Care

Keywords

Integrated care, Health and social care, Chronic disease, Primary Health Care, Quality of life

Brief summary

Integrated care models aim to promote the coordination and communication between services. The present study aim to evaluate the effectiveness of a new integrated care model (Salut+Social model) which will promote the coordination and communication between social and healthcare services in southern Catalonia (Spain) for the improvement of quality of life of chronic patients, adherence to treatment, access to medical services and caregiver overload. Also, we will evaluate the experience of health and social professionals with the new model implemented.

Detailed description

A clinical trial with mixed methodology will be carried out. The intervention consists of the promotion and coordination between the social and health sectors, for 6 months, through the use of information and communication technology (ICT) tools that operate as an interface for the integrated care model. The study subjects are chronic patients with health and social conditions that are susceptible to be treated in a collaborative and coordinated way in the field of primary health care. A sample size of 141 patients was estimated. Questionnaires will be used at baseline and at 6, 9 and 12 months after the beginning of the study for the evaluation of quality of life, treatment adherence, medical service and caregiver overload. The principal variable is the quality of life. For statistical analysis, comparisons of means and proportions at different time points will be performed. One discussion group will be performed with the aim of improving the care model according to professionals' opinions. A thematic content analysis will be carried out.

Interventions

OTHERintegrated-care-model benefiting group

Patients will be called for the first interview of the study by the healthcare professional. Their data will be automatically entered in the Salut + Social app, they will be asked to respond to the study questionnaires (ad hoc questionnaire for sociodemographic data, EuroQol-5D, Zarit questionnaire and Morisky-Green test) and will take part in the future actions to be planned for them. Patients will receive an appointment to attend their PCC at 6, 9, and 12 months after their incorporation into the program. In those follow-up, the same questionnaires will be provided together with the IEXPAC questionnaire, which evaluates the experience of the chronic patient with the new care model.

Sponsors

Institut Català de la Salut
CollaboratorOTHER
Department of Health, Generalitat de Catalunya
CollaboratorOTHER_GOV
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Adult patients with at least one health and one social condition, as below specified: 1. health condition, according to diagnosis of the electronic medical history: complex chronic patient; advanced chronic disease; patient in the home care program; dementia; neurodegenerative diseases; stroke; others chronic disease. 2. social condition, according to social service workstation from Ribera d'Ebre district: dependence grade; home social service assistance; teleassistance systems assigned by home support. * Knowledgement of Spanish or Catalan. * Accepting participation in the study (with informed consent signed by the patient or by the caregiver).

Exclusion criteria

* Institutionalized patients. * Users with difficulties filling out or respond a questionnaire.

Design outcomes

Primary

MeasureTime frameDescription
Change in patient experience about his/her carechange from IEXPAC at 6, 9 and 12 months after the beginning of the studyBe evaluated with the IEXPAC (Instrument for the Evaluation of the Chronic Patient's Experience). Each of the 11 items will be measured with 5-point Likert scale. The global punctuation is an average of the score of the each of the items: 0 (worst experience) to 10 (best experience).
Change in life qualitychange from life quality at 6, 9 and 12 months after the beginning of the study.to be evaluated with the EuroQol- 5 Dimension (EQ-5D). It will be measured by a scale Likert: 0 (worst) to 1 (best).
Change in caregiver burdenchange from Zarit Caregiver Burden Inventory at 6, 9 and 12 months after the beginning of the study.to be evaluated with the Zarit Caregiver Burden Inventory. It will be measured by a scale Likert: 22 (best) to 110 (worst).
Change in adherence to treatmentchange from Morisky and Green test at 6, 9 and 12 months after the beginning of the study.be evaluated with the Morisky and Green test. It will be measured with a dichotomic variable: compliant (if response for the 4 questions is: No/Yes/No/No); noncompliant (if response for the 4 questions is different for: No/Yes/No/No).

Secondary

MeasureTime frameDescription
Sociodemographic characteristics of the patientsbaseline (pre intervention period)age, sex, level of education, civil status, job situation, nationality
Caregiver characteristics: caregiver with family relationshipbaseline (pre intervention period)To be evaluated with an ad hoc questionnaire (yes/no type)
Caregiver characteristics: caregiver relationshipbaseline (pre intervention period)To be evaluated with an ad hoc questionnaire (1. Couple; 2. Mother; 3. Father; 4. Son; 5. Others).
Caregiver characteristics: hours of supportbaseline (pre intervention period)To be evaluated with an ad hoc questionnaire (quantitative variable).

Countries

Spain

Contacts

Primary ContactPere M Zaragoza, BSc
pmonteagudo@idiapjgol.org+34 934824253
Backup ContactAlessandra Q Gonçalves, PhD
aqueiroga@idiapjgol.info+34 977504949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026